Safety and Efficacy of Peginesatide Injection for the Maintenance of Anemia in Chronic Renal Failure Participants Who Are on Hemodialysis or Do Not Require Dialysis and Previously Treated With Darbepoetin Alfa.
This study has been completed.
Study NCT00752609
Information provided by Takeda Global Research & Development Center, Inc.
First Received on September 11, 2008.
Last Updated on June 26, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study: